Hikma Pharmaceuticals PLC subject to approval at 25 April 2024 Annual General Meeting, company will be paying a final dividend of 47 cents per share. The final dividend brings the total dividend for the full year 2023 to 72 cents per share, an increase of 29% on 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,956 GBX | -0.20% | +1.66% | +9.33% |
03/05 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
03/05 | Jefferies cuts AJ Bell; Deutsche likes ConvaTec | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.33% | 5.44B | |
+33.43% | 700B | |
+26.43% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+14.32% | 236B | |
+5.79% | 202B | |
-9.49% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals PLC Proposes Final Dividend for the Full Year 2023